UNSPSC 85752645: Removal of autologous tissue substitute from vas deferens, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of autologous tissue substitute from vas deferens, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0VPR47Z

UNSPSC 85752645 Removal of autologous tissue substitute from vas deferens, percutaneous endoscopic approach is a Commodity code that shows no meaningful recent state and local procurement activity aligned with its clinical scope. The six most-recent opportunities posted under this code — solicitations from the City of Phoenix Retirement Office, City of Long Beach, Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and County of Santa Clara Health System — are purchasing independent medical evaluation services for disability determinations, surgical benefit carve-out programs, occupational medical surveillance, emergency and specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these represent procurement of the specific urological procedure named in the code.

The mismatch between the code's nominal scope and the work actually being solicited signals either a systematic classification error in the state and local procurement systems tagging these opportunities or a code that does not reflect meaningful category activity in public-sector contracting. State and local governments do not appear to be purchasing vas deferens tissue-substitute removal services as discrete line items. If your firm specializes in this procedure or related urological services, this code warrants review with procurement classification teams at target jurisdictions to confirm whether opportunities in this clinical domain are being tagged differently or consolidated under higher-tier medical codes; absent that clarification, pursuit under this specific commodity code is not supported by current market signals.